| | Business Summary | | Duramed
Pharmaceuticals,
Inc.
develops,
manufactures
and
markets
a
line
of
prescription
drug
products
in
tablet,
capsule
and
liquid
forms
to
customers
throughout
the
United
States.
Products
sold
by
the
Company
include
those
of
its
own
manufacture
and
those
it
markets
under
arrangements
with
other
drug
manufacturers.
The
Company
sells
its
products
to
drugstore
chains,
drug
wholesalers,
private
label
distributors,
health
maintenance
organizations,
hospitals,
nursing
homes,
retiree
organizations,
mail-order
distributors,
other
drug
manufacturers,
mass
merchandisers
and
governmental
agencies.
A
key
aspect
of
the
Company's
strategic
business
plan
has
been
to
develop
a
portfolio
of
brand
and
generic
female
hormone
products
focused
in
the
estrogen
replacement
therapy,
hormone
replacement
therapy
and
oral
contraceptive
categories. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Duramed
Pharmaceuticals
develops,
manufactures
and
markets
a
line
of
prescription
generic
drug
products,
in
tablet,
capsule
and
liquid
forms.
For
the
six
months
ended
6/30/01,
revenues
rose
61%
to
$59.8
million.
Net
income
applicable
to
Common
totaled
$4.9
million
vs.
a
loss
of
$2.4
million.
Revenues
reflect
an
increase
in
sales
of
hormone
products
and
seasonal
cough/cold
products.
Earnings
also
reflect
higher
gross
and
operating
margins
and
lower
interest
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| E. Thomas Arington, 64
Chairman,
CEO | $517K | -- | Jeffrey Arington, 40
Pres,
COO, Director | 235K | -- | Timothy Holt, 48
CFO,
Sr. VP of Fin. and Admin. and Treasurer | 216K | $60K | Lawrence Glassman, 39
Sr.
VP, Gen. Counsel | 132K | -- | S. Sundararaman, 64
Sec. | -- | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/d/drmd.gif)